ParcelBio Launches with $13 Million in Financing to Advance Next-Generation mRNA Medicines
SAN FRANCISCO–(BUSINESS WIRE)–ParcelBio, a biotechnology company developing a new class of potent and durable mRNA medicines, today announced it has raised $13 million in seed financing led by Breyer Capital, with participation from General Catalyst,…